Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

HDFC Life Insurance Company - Well placed to benefit from strong demand outlook - ICICI Securities

Posted On: 2021-06-21 16:25:10 (Time Zone: UTC)


We reiterate our BUY rating on HDFC Life led by better outlook of non-par guaranteed portfolio, continued strong demand for protection and organic growth levers.

- Increase in guaranteed rates and likely increase in interest rates ahead will make non-par portfolio more attractive. HDFC Life has increased rates in its guaranteed savings offering. When we look at derivative (FRA) MTMs, some peers have reported losses in FY21 indicating interest rates have been higher than the exercise rates of these derivatives. This, along with possible increase in interest rate outlook, will enable insurers to offer higher rates for their non-par guaranteed portfolio. HDFC Life is well placed to benefit from this. Our channel checks indicate healthy demand for this segment. Non-par savings was 26% of total APE in FY21 and has room to increase (it was 34% of mix in FY20). Higher non-par mix will lead to improvement in margins.

- Sum assured growth has also been healthy for HDFC Life. The individual sum assured market share for HDFC Life has improved from 11.7%/11.2% in FY20/21 to 14.3% FY22TD (data up to May'21). The group sum assured market share of HDFC Life stands at 9.3% as of May'21 compared to 24/12% in FY20/21 indicating a possible scope of improvement.

- Multiple growth levers remain in place including 1) recovery of credit protect NBP (26% YoY growth in Q4FY21 though it declined 19% in FY21); 2) higher growth in agency/direct business, up 8% / 0.1% in FY21 (HDLI also forged new partnerships in FY21 with Yes Bank, SBI Capital Markets, State Bank of Mauritius, Doha Bank, Edelweiss); and 3) better enablement of medical underwriting (HDLI followed a calibrated growth strategy in retail protection due to supply-side constraints and headwinds to medical testing, especially beyond tier-1 locations).

- Covid claims remain a short-term concern. Depending upon the provisions already taken in FY21, insurers might have to take additional provisioning in FY22. However, this remains a one-off event (HDFC Life had no negative operational variance between FY16-20). Overall demand for protection remains very strong. Higher pricing and improved medical underwriting are available profit levers.

- Reiterate BUY. We factor VNB margins of 27/28.5% with APE growth of 18/18% in FY22/FY23E. We expect HDLI to accumulate Rs58.7bn of new business and Rs45.4bn of unwind (@8%) over FY22E / FY23E to reach an embedded value (EV) of Rs358.3bn by FY23E. We value HDLI based on 40x new business value of Rs33bn in FY23E to arrive at a target price of Rs823. At our target price, the stock will trade at 4.6x FY23E P/EV. We factor negative variance of Rs10bn in FY22 to counter possible covid claims and change in interest rates.

Shares of HDFC Life Insurance Company Ltd was last trading in BSE at Rs.718.35 as compared to the previous close of Rs. 709.2. The total number of shares traded during the day was 325723 in over 15184 trades.

The stock hit an intraday high of Rs. 719.65 and intraday low of 704.2. The net turnover during the day was Rs. 232751017.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Ambuja Cements Ltd: Q2CY21 Result update - YES Securities

Q1FY22 Result Update - Polycab India - ICICI Direct

Q1FY22 Result Update - Hindustan Zinc - ICICI Direct

Federal Bank - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Biocon Ltd - ICICI Direct

IPO Review - Glenmark Life Sciences Ltd - ICICI Direct

JSW Steel - Q1FY22 First Cut - ICICI Direct

Crompton Greaves Consumer Electricals - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - CSB Bank - ICICI Direct

SKF India - Q1FY22 First Cut - ICICI Direct

Company Update - Gandhi Special Tubes - ICICI Direct

Q1FY22 Result Update - Hindustan Unilever - ICICI Direct

Q1FY22 Company Update - Mphasis - ICICI Direct

Maintain REDUCE on Hindustan Unilever - Steady performance continues - HDFC Securities

Maintain ADD on Havells India - Robust performance despite the odds - HDFC Securities

Maintain BUY on Bajaj Auto - Laying the ground for future technologies - HDFC Securities

Maintain BUY on UltraTech Cement - UltraHigh! Margin at its best ever; outlook strong - HDFC Securities

ICICI Lombard Report - Not in the pink: spike in health claims affects loss ratio - HDFC Securities

Hindustan Zinc - Higher commodity continues to propel earnings - ICICI Securities

ICICI Lombard General Insurance Company - Q1FY22 Update - ICICI Direct

UltraTech Cement - EBITDA/te inches to highest-ever Rs1,600/te - ICICI Securities

Arvind Fashions Ltd - A step in the right direction - ICICI Securities

CEAT - RM cost pressures likely to stay elevated - ICICI Securities

Hindustan Unilever - (Re) Investing (margins) for growth - ICICI Securities

Mahindra CIE Automotive - Growth outlook remains healthy - ICICI Securities

Bajaj Auto - Tough quarter; export outlook remains solid - ICICI Securities

Mphasis - Q1 FY22 first cut - YES Securities

Can Fin Homes - Q1 FY22 first cut - YES Securities

Sterlite Technologies - Q1 FY22 first cut - YES Securities

IndiaMart - Q1 FY22 first cut (Current Rating: BUY) - YES Securities

Schaeffler Q2CY21 call highlights (Rating: NOT RATED) - YES Securities

CEAT 1QFY22 call highlights (Rating: NOT RATED) - YES Securities

Bajaj Auto 1QFY22 first cut & call highlights (Rating: NOT RATED) - YES Securities

ICICI Lombard - Q1 FY22 Result Report - YES Securities

Hindustan Unilever - Q1 FY22 Result Report - YES Securities

Avenue Supermart - Q1 FY22 Result Report - YES Securities

Ultratech Cement - Q1 FY22 Result Report - YES Securities

Havells India - Q1 FY22 Result Report - YES Securities

Polycab India - Q1 FY22 Result Report - YES Securities

Q1FY22 Result Update - Bajaj Auto - ICICI Direct

Q1FY22 Result Update - Sterlite Technologies - ICICI Direct

Q1FY22 Result Update - UltraTech Cement - ICICI Direct

Biocon - Q1FY22 First Cut - ICICI Direct

Gladiator Stocks - Bharti Airtel - ICICI Direct

Q1FY22 Result Update - Rallis India - ICICI Direct

Q1FY22 Result Update - Havells India - ICICI Direct

Q1FY22 Result Update - Syngene International - ICICI Direct

Sterlite Technologies - Q1FY22 First Cut - ICICI Direct

Bajaj Auto - Q1FY22 First Cut - ICICI Direct

UltraTech Cement - Q1FY22 First Cut - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020